“Computational Design and Molecular Docking of Perimidine–Peptide Hybrids as Next-Generation Topoisomerase IIα Inhibitors” (2025) Pakistan Journal of Medical & Cardiological Review, 4(4), pp. 814–822. doi:10.64105/sz2xqc34.